Dengue and thrombotic thrombocytopenic purpura
openaire +2 more sources
Monitoring ADAMTS-13 conformation in immune-mediated thrombotic thrombocytopenic purpura: toward personalized management. [PDF]
Joly BS +5 more
europepmc +1 more source
Continuity of care in immune thrombotic thrombocytopenic purpura (iTTP): A visual roadmap for survivorship beyond acute management. [PDF]
Qiao J, Tran MH, Jones J, Simmons S.
europepmc +1 more source
A Retrospective Analysis of ADAMTS13 Enzymatic Activity Results in a Population With Thrombotic Thrombocytopenic Purpura Disease in the Arabian Gulf and Colombia (APOLO Study). [PDF]
Edris S +8 more
europepmc +1 more source
Hematologic safety of caplacizumab in immune-mediated thrombotic thrombocytopenic purpura: insights from platelet-related signal detection in the FAERS database. [PDF]
Liu Z, Ye X.
europepmc +1 more source
Clinical characteristics and treatment response of patients with SLE complicated with thrombotic thrombocytopenic purpura. [PDF]
Zhang K +17 more
europepmc +1 more source
Health-related quality of life and mental health in autoimmune thrombotic thrombocytopenic purpura patients in the caplacizumab era. [PDF]
Weisinger J +19 more
europepmc +1 more source
EASIX, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpura. [PDF]
Escribano-Serrat S +19 more
europepmc +1 more source

